用药依从性与视野进展的关联:CIGTS研究
CIGTS是一项随机多中心临床试验,比较初诊青光眼患者初始药物治疗与 trabeculectomy。
要点
- 用药依从性越差,视野MD丢失越多(P=0.005)。
- 从不漏药者8年MD丢失0.62 dB,漏药达1/3就诊次数者丢失1.42 dB。
- 漏药达2/3就诊次数者8年MD丢失2.23 dB。
核心结论
- 用药不依从与青光眼性视野丢失存在统计学和临床显著的关联。
研究设计与样本
- CIGTS为随机多中心临床试验,比较初诊青光眼初始局部药物与 trabeculectomy,共607例。
主要发现
- 依从性越差,MD随时间丢失越多(P=0.005)。
- 从不漏药者8年平均预测MD丢失0.62 dB(95%CI 0.17-1.06;P=0.007)。
- 漏药达1/3就诊次数者丢失1.42 dB(95%CI 0.86-1.98;P<0.0001);漏药达2/3者丢失2.23 dB(95%CI 1.19-3.26;P<0.0001)。
临床怎么用
- 应重视青光眼患者用药依从性评估,依从性差者视野进展风险更高。
局限性
- 依从性基于电话自我报告,可能存在回忆偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the relationship between medication adherence and visual field progression in participants randomized to the medication arm of the Collaborative Initial Glaucoma Treatment Study (CIGTS). DESIGN: The CIGTS was a randomized, multicenter clinical trial comparing initial treatment with topical medications to trabeculectomy for 607 participants with newly diagnosed glaucoma. PARTICIPANTS: Three hundred seven participants randomized to the medication arm of the CIGTS. METHODS: Participants were followed up at 6-month intervals for up to 10 years. Self-reported medication adherence and visual fields were measured. Medication adherence was assessed by telephone from responses to the question, "Did you happen to miss any dose of your medication yesterday?" The impact of medication adherence on mean deviation (MD) over time was assessed with a linear mixed regression model adjusting for the effects of baseline MD and age, cataract extraction, interactions, and time (through year 8, excluding time after crossover to surgery). Medication adherence was modeled as a cumulative sum of the number of prior visits where a missed dose of medication was reported. MAIN OUTCOME MEASURE: Mean deviation over time. RESULTS: Three hundred seven subjects (306 with adherence data) were randomized to treatment with topical medications and followed up for an average of 7.3 years (standard deviation, 2.3 years). One hundred forty-two subjects (46%) reported never missing a dose of medication over all available follow-up, 112 patients (37%) reported missing medication at up to one third of visits, 31 patients (10%) reported missing medication at one third to two thirds of visits, and 21 patients (7%) reported missing medication at more than two thirds of visits. Worse medication adherence was associated with loss of MD over time (P = 0.005). For subjects who reported never missing a dose of medication, the average predicted MD loss over 8 years was 0.62 dB, consistent with age-related loss (95% confidence interval [CI], 0.17-1.06; P = 0.007); subjects who reported missing medication doses at one third of visits had a loss of 1.42 dB (95% CI, 0.86-1.98; P < 0.0001); and subjects who reported missing medication doses at two thirds of visits showed a loss of 2.23 dB (95% CI, 1.19-3.26; P < 0.0001). CONCLUSIONS: This longitudinal assessment demonstrated a statistically and clinically significant association between medication nonadherence and glaucomatous vision loss.
引用
- Newman-Casey PA, Niziol LM, Gillespie BW, et al. The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2020. PMID: 31932093. doi:10.1016/j.ophtha.2019.10.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。